Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引：0
|
作者：
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构：
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF FARICIMAB IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CANADA
    Buhrer, C.
    Paulo, T.
    Diles, D.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S111 - S112
  • [42] Real-world frequency and outcomes of intraocular inflammation-related adverse events in eyes with neovascular age-related macular degeneration treated with brolucizumab
    Mccoy, Jasmyne E.
    Zubricky, Ryan
    Donkor, Richard
    Miller, David G.
    Sonbolian, Nina
    Heaney, Andrew
    Bilano, Ver
    Karcher, Helene
    Coney, Joseph M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [43] Visual outcomes in patients with neovascular age-related macular degeneration
    Tan, Colin S.
    Ngo, Wei Kiong
    Lim, Louis W.
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 (02) : e254 - e254
  • [44] Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study
    Holz, Frank G.
    Minnella, Angelo M.
    Tuli, Raman
    Yoganathan, Pradeepa
    Parikh, Soumil
    Hamilton, Robin
    [J]. PLOS ONE, 2020, 15 (12):
  • [45] Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
    Daien, Vincent
    Finger, Robert P.
    Talks, James S.
    Mitchell, Paul
    Wong, Tien Y.
    Sakamoto, Taiji
    Eldem, Bora M.
    Korobelnik, Jean-Francois
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (11) : 1475 - 1479
  • [46] Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study
    Chakraborty, Debdulal
    Maiti, Aniruddha
    Sheth, Jay U.
    Boral, Subhendu
    Mondal, Soumen
    Nandi, Krishnendu
    Sinha, Tushar
    Das, Arnab
    [J]. CLINICAL OPHTHALMOLOGY, 2021, 15 : 3787 - 3795
  • [47] 4 YEAR REAL-WORLD OUTCOMES OF RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE RELATED MACULAR DEGENERATION
    Chew, Jamie
    Broadhead, Geoffrey
    Li, Haitao
    Chang, Andrew
    [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 107 - 107
  • [48] Real-world rapid mean visual acuity improvement in patients initiated on aflibercept therapy for treatment-naive neovascular age-related macular degeneration (nAMD)
    Crosby-Nwaobi, Roxanne R.
    Hykin, Philip G.
    Sivaprasad, Sobha
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [49] Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
    Zubricky, Ryan
    McCoy, Jasmyne
    Donkor, Richard
    Miller, David G.
    Sonbolian, Nina
    Heaney, Andrew
    Bilano, Ver
    Karcher, Helene
    Coney, Joseph M.
    [J]. OPHTHALMOLOGY AND THERAPY, 2023, 12 (05) : 2397 - 2408
  • [50] Real-World Frequency and Management of Ocular Adverse Events in Eyes with Neovascular Age-Related Macular Degeneration Treated with Brolucizumab
    Ryan Zubricky
    Jasmyne McCoy
    Richard Donkor
    David G. Miller
    Nina Sonbolian
    Andrew Heaney
    Ver Bilano
    Helene Karcher
    Joseph M. Coney
    [J]. Ophthalmology and Therapy, 2023, 12 : 2397 - 2408
12345